Joint Formulary & PAD

Cyproheptadine hydrochloride - Serotonin syndrome

You are here : Home > Formulary Search > Cyproheptadine hydrochloride - Serotonin syndrome

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Cyproheptadine hydrochloride
Indication :
Serotonin syndrome
Group Name :
Keywords :
Brand Names Include :
Periactin
Important Information :

https://www.toxbase.org/

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Cyproheptadine hydrochloride is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Serotonin syndrome.

  • No records returned.